Lisinopril - NDC Database (Page 33)
935 records found
Start a Discussion
50090-6303 Jun 01, 2021
Lisinopril 40 mg Oral Tablet by A-s Medication Solutions
50090-6860 Nov 01, 2011
Lisinopril 2.5 mg Oral Tablet by A-s Medication Solutions
50090-6912 Nov 01, 2011
Lisinopril 5 mg Oral Tablet by A-s Medication Solutions
50090-7022 May 12, 2017
Lisinopril 10 mg Oral Tablet by A-s Medication Solutions
50090-7074 Nov 01, 2011
Lisinopril 40 mg Oral Tablet by A-s Medication Solutions
50090-7221 May 12, 2017
Lisinopril 10 mg Oral Tablet by A-s Medication Solutions
50090-7650 Jun 01, 2021
Lisinopril 40 mg Oral Tablet by A-s Medication Solutions
50436-0353 Nov 01, 2011
Lisinopril 10 mg Oral Tablet by Unit Dose Services
50436-0354 Nov 01, 2011
Lisinopril 20 mg Oral Tablet by Unit Dose Services
50436-0376 Jun 02, 2016
Lisinopril 5 mg Oral Tablet by Unit Dose Services
51138-067 Jan 05, 2011
Lisinopril 30 mg Oral Tablet by Med-health Pharma, LLC
51655-146 Jul 11, 2022
Lisinopril 40 mg Oral Tablet by Northwind Pharmaceuticals, LLC
51655-335 May 21, 2020
Lisinopril 40 mg Oral Tablet by Northwind Pharmaceuticals
51655-399 Apr 27, 2020
Lisinopril 10 mg Oral Tablet by Northwind Pharmaceuticals
51655-401 May 20, 2014
Lisinopril 10 mg/301 Oral Tablet by Northwind Pharmaceuticals
51655-411 Mar 13, 2020
Lisinopril 20 mg Oral Tablet by Northwind Pharmaceuticals
51655-486 Nov 23, 2020
Lisinopril 5 mg Oral Tablet by Northwind Pharmaceuticals
51655-707 May 07, 2021
Lisinopril 40 mg Oral Tablet by Northwind Pharmaceuticals
51655-729 Jun 16, 2021
Lisinopril 2.5 mg Oral Tablet by Northwind Pharmaceuticals, LLC
51655-994 Jun 27, 2022
Lisinopril 20 mg Oral Tablet by Northwind Pharmaceuticals
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us .
